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ABSTRACT 
 
 
HEALTH CARE INFORMATICS SUPPORT OF A SIMULATED STUDY 
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Under the Supervision of Professor Peter J Tonellato 
and 
 Professor Timothy B Patrick 
 
 
 
The objective of this project is to assess the value of REDCap (Harris, 2009) by 
conducting a simulated breast cancer clinical trial and demonstration. REDCap is a free, 
secure, web-based application designed to support data capture for research studies.  To 
assess REDCap‟s value, we conducted a simulation of a clinical trial study designed to 
compare the use of two new technologies for breast cancer diagnosis and treatment with 
current best practice breast cancer diagnosis and treatment. We call the trial, “Real-Time 
Operating Room BC Diagnostic Treatment (RORBCDT)”. The RORBCDT clinical trial 
is designed to assess the value of a new breast cancer operating room diagnostic 
technology “Intra-operative diagnosis of Sentinel Lymph Node (Sentimag)”( Keshtgar, 
n.d) and real-time treatment option “Intra-operative Radiotherapy (IORT)”( Williams, 
2011.) A Sentimag is used to “stage” certain cancers to determine their degree of spread 
to lymph nodes. If the diagnose is positive, then the new treatment device (IORT) is used 
to treat the remaining cancerous tissue.  
This Clinical Trial simulation consists of several steps:  
  
iii 
 
1. Design the clinical trial  
2. Create the REDCap project environment to conduct the trial  
3. Recruit and train fictitious patients, providers and project team.  
4. Execute the simulated trial  
5. Assess the value of REDCap in conducting the simulation.  
Note: This entire exercise is a SIMULATION – no actual patients, physicians or 
devices were used.  Rather, a simulated clinical trial was performed with trained 
volunteers pretending to be patients, physicians and research staff.  Consequently, the 
assessment of REDCap and all results, conclusions and observations are based on a 
SIMULATION.  The simulated clinical trial - RORBCDT - is a two arm clinical trial 
designed to test the efficacy of the real-time diagnostic (Sentimag) and treatment (IORT) 
devices. In one arm of the trial, breast cancer surgery patients (volunteers not real 
patients) will experience a simulated best practice operation and therapy. In the other 
arm, breast cancer surgery patients (volunteers not real patients) will experience a 
simulated real-time diagnosis and treatment using the intra-operative devices. This 
research seeks to execute a fictitious clinical trial to assess the value of REDCap.  
We anticipate that this simulation and those similar to it, will help health care 
researchers become familiar with REDCap and  assess REDCap‟s value and use in 
conducting health research. 
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Introduction to Health Care Informatics
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Introduction to Health Care Informatics 
In 2009, William Hersh defined “Health Information Technology (HIT) as the 
term used to describe the application of computers and technology in health care settings” 
(Hersh, 2009).  Hersh also defined “informatics” as “the discipline focused on the 
acquisition, storage, and use of information in a specific setting or domain” (Hersh, 
2009). Informatics is more about information than technology, but information has its 
roots in a domain and it distinguishes that from information and information science. The 
former School of Informatics at the State University of New York Buffalo defined 
informatics as the intersection of the people, information, and technology. Charles 
Friedman has defined his "fundamental theorem" of informatics, Three corollaries 
illustrate that informatics is more about people than technology and states that 
informatics is more about using technology to help people do cognitive tasks better than 
about building systems to mimic or replace human expertise (Friedman, 2009). 
Reinold Haux (Haux, 1997) defined “Medical Informatics” as the discipline 
concerned with systematic processing of data, information and knowledge in medicine 
and health care. The domain of medical informatics covers computational and 
informational aspects of processes and structures in medicine and health care. The aims 
of medical informatics are: To provide solutions for problems related to data, information 
and knowledge processing and to study general principles of processing data, information 
and knowledge in medicine and health care. The ultimate goal of medical informatics 
should always be to improve quality of health care, and to improve research education in 
medicine and in the health sciences (Haux, 1997). 
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 In 2009, President Barack Obama stated that "We have the most inefficient 
health care system imaginable. We're still using paper. Nurses can't read the prescriptions 
that doctors have written out. Why wouldn't we want to put that on an electronic medical 
record that will reduce error rates, reduce our long term costs of health care, and create 
jobs right now?" (Bernie Monegain, 2009). Since, HIT was elevated to new prominence 
in the US by inclusion in the American Recovery and Reinvestment Act (ARRA) of 2009, 
the federal economic stimulus package signed into law by President Barack Obama on 
February 17, 2009 (Hersh, 2009). 
When health records were first computerized, the term electronic medical record (EMR) 
was most commonly used. However, this has mostly been supplanted by the term 
electronic health record (EHR), which implies a broader and more longitudinal collection 
of information about the patient (Detmer, 2008). 
Clinical informaticians are playing an important role in transition from paper 
records to electronic ones. Recently, the number of electronic solutions and applications 
to manage electronic health record have been increasing.  
In the 1990s Electronic Data Capture (EDC) was referred to “remote data 
capture” (RDC). They were essentially data “silos” that had no easily ability to 
interchange their data with other systems. Today, the integration of EDC software with 
other types of software in the eClinical spectrum (randomization, supply management, 
adverse event reporting, coding, submissions, etc.) systems is increasingly feasible and 
beneficial. The ability to quickly and reliably import electronic data from other sources 
(such as lab reports, imaging data sources, and electronic health records) is also 
becoming commonplace. The rise of open source EDC software and independent 
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standards for characterizing and sharing data are key enablers towards accelerating the 
productivity and decreasing the cost and burden associated with clinical trials 
(OpenClinica, n.d). 
Therefore, clinical informaticians who bring expertise at the intersection of health 
care and IT to assure successful adoption and use of HIT and the information within it are 
responsible to assess the values of different applications prior to adopting them in their 
health facilities. These individuals also optimize the use of information though leadership 
of clinical staff, organizing and structuring information for its direct and secondary use, 
and serving as a bridge between IT and clinical personnel (Hersh, 2009). 
In the past ten years, Medical Informatics has evolved from a more conceptual 
approach to improving healthcare to a funded, well coumented science that has achieved 
a number of substantial outcomes and is funded through ARRA to help change the 
practical approach and use of HIT in best care practice.  One important role of Medical 
Informaticians, is to provide insight and value of the tools, methods and approaches that 
medical informatics produces.  The objective of this thesis is to conduct a low cost, 
highly efficient, yet representative clinical trial simulation to demonstrate the value on 
one of the most promising medical informatics systems – REDCap. 
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Chapter 2 
Clinical Trial Management System
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Needs for Clinical Trial Management System 
A clinical trial is a research study in which a treatment or therapy is tested in 
people to observe whether it is safe and effective. The information obtained from clinical 
trials helps to improve health care and to keep people healthier. It is also conducted by 
researchers to find out which treatments are more effective than others. The results of 
clinical studies give better knowledge about diseases and its conditions (Shweta, 2007). 
A Clinical Trial Management System (CTMS) is software to manage the large amount of 
data in clinical trial studies. The software is customizable to maintain and manage the 
planning, preparation, performance, and reporting of clinical trials. In addition, it can 
track deadlines and milestones in targeted clinical trial. According to Thomson 
CenterWatch, in 2004, pharmaceutical sponsors used Electronic Data Capture EDC 
and/or interactive voice response systems (IVRS) in 44 percent of Phases I - IV clinical 
trials (Korieth, 2005). 
The number of clinical trials and their complexity is growing accompanied by 
longer trial duration. The costs for conducting clinical trials are rapidly increasing and 
manual and paper based methods are no longer useful to manage clinical trials. 
Therefore, there is a need for a better method to help investigators reduce trial length and 
manage huge amount of data and reduce expenditure. Clinical trials are increasingly 
global in nature and conducted across multiple geographies. Making trial information 
accessible to the right people at the right time with the right level of detail becomes ever 
more critical. 
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Assessment of options 
The cost of purchasing and supporting major vendor solutions for clinical data 
management systems can be prohibitive (Value of Hosted Clinical Data Environments, 
n.d). Although costs can be justified in large organizations running multiple sponsored 
clinical trials, the academic research environment is typically home to many preclinical 
investigator-initiated research studies requiring a fraction of the subjects needed for 
larger trials. In these cases, traditional EDC setup time for CRFs and software expense 
may outweigh benefits for the study (Weber, 2005). 
An Electronic Data Capture (EDC) system is a computerized system designed for 
the collection of clinical data in electronic format for use mainly in human clinical trials. 
Modern electronic data capture software is typically web-based, which means that the 
software runs entirely on a web server and utilizes a thin client which means that the only 
tool you need is an ordinary web browser connected to the internet in order to access and 
utilize the EDC software. Clinical trial data may be captured electronically or in paper 
form and later transcribed into the EDC system (OpenClinica, n.d). 
The REDCap (Research Electronic Data Capture) is a free, secure, web-based 
application designed to support data capture for translational and clinical research studies 
and provides a rapid-development and flexible informatics systems-based approach to 
supporting studies (Harris, 2009).The system was developed by a multi-institutional 
consortium initiated at Vanderbilt University. 
REDCap enables global clinical organizations to maintain a centralized trial 
management database while providing users with the most relevant and appropriate 
information based on their specific roles and responsibilities. Data collection is 
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customized for each study or clinical trial by the research team. REDCap is usefull for 
Collecting and tracking information and data from research studies, scheduling study 
events (e.g., patient visits) and conducting surveys (Appendix A). 
Why REDCap for this Project? 
REDCap offers the following features which are very useful to collect data for research 
studies and conduct different kind of projects (e.g. longitudinal projects). REDCap has 
been developed over two years by a wide collection of investigators and developers 
(Harris, 2009). Many validation projects have been conducted and after this effort 
REDCap is: 
 Fast and has Quick project start-up. Clinical report forms can be 
implemented      without the need for a programmer.  
 Easy. It has intuitive user interface and work flow, online training 
materials      which is readily available.   
 Fully customizable. You are in control of shaping your database.  
 Secure. It has backed up offsite nightly and hosted in a secure environment. 
 Web-based. You are able to enter data or build your database from anywhere in 
the world over a secure web connection with authentication and data logging. 
This feature will help to conduct collaborative studies. 
 A data export tool. You can export data to common data analysis packages, 
data export function for Excel, SAS, Stata, R, and SPSS.  
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 A data import tool. It has data import capability through Microsoft Excel. 
 A multi-site utility. It can be used by researchers from multiple sites and 
institutions. 
 An autonomous user management tool. Research groups have complete 
autonomy and control to add new users and set several levels of specific user 
rights. 
REDCap has some advanced features including mid-study modifications, auto-validation, 
branching logic, and calculated fields. 
Research Objective 
According to Haux's statement, the essential aims of medical informatics are 
diagnostic, therapy, therapy simulation, early recognition and prevention, compensating 
physical handicaps, health consulting, health reporting, health care information systems, 
medical documentation, comprehensive documentation of medical knowledge and 
knowledge-based decision support.  
As Haux stated, in some cases, simulation of the intervention will result in 
considerably improved therapy quality, but we have to ask ourselves in what extent we 
can simulate a therapeutical intervention close to reality (Haux, 1997). 
The objective of this project is to demonstrate the value of REDCap (Harris, 
2009) by conducting a simulated breast cancer clinical trial process. 
Simulation is the imitation of the operation of a real-world process or system over 
time (Banks, 1984). The breast cancer clinical trial simulation is called, Real-Time 
Operating Room Breast Cancer Diagnostic Treatment (RORBCDT). The RORBCDT 
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clinical trial is designed to assess the value of a new breast cancer operating room 
diagnostic technology “Intra-operative Diagnosis of Sentinel Lymph Node (Sentimag)” ( 
Keshtgar, n.d) and real-time treatment option “Intra-operative Radiotherapy (IORT)” ( 
Williams, 2011). Sentimag can detect for staging of certain types of cancer to see if they 
have spread to any lymph nodes. If the diagnose is positive, then the surgery will apply 
and then a new treatment device (IORT) can be used to treat the remaining cancerous 
tissues.  
The outcome of this simulation will be an executed clinical trial process in 
REDCap environment. The entire project will be conducted using fictitious patients, 
physicians and clinical trial team who will be trained to participate in the simulation as 
real patients, physicians and clinical trial staff.  
Clinical Trial Preparation 
This Project will include several steps: 
1. Install REDCap on a local system. 
Laboratory for Public Health Informatics and Genomics (LPHIG) at 
university of Wisconsin-Milwaukee, Ziber School of Public Health should 
become REDCap Partner. Then REDCap will install on both local Windows 
and Linux system by research coordinator. (Appendices B, C). 
2. Design the clinical trial. 
The research coordinator will design a clinical trial simulation to implement in 
REDCap Environment. 
3. Create REDCap project environment to conduct trial. 
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REDCap environment will be created in order to conduct the simulation. Then 
the simulated trial will be implemented in REDCap environment. 
4. Recruit and train fictitious patients, physicians and project team. 
The required fictitious participants (Patients, Physicians, Research team, etc) 
will be hired and trained to participate and execute the trial. 
5. Execute the trial. 
The simulated Trial will be executed in REDCap environment by research 
team. 
6. Assess the Value of REDCap. 
The fictitious results will analyzed and used to show the Value of REDCap in 
health domain especially in clinical studies (Appendix G.)
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Chapter 3 
Clinical Trial Simulation
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Simulation of 
 Real-Time Operating Room Breast Cancer Diagnostic Treatment Clinical Trial 
 
The objective of this project is to demonstrate the value of REDCap (Harris, 
2009) by conducting a simulated breast cancer clinical trial and demonstration. The 
breast cancer clinical trial is called, Real-Time Operating Room Breast Cancer 
Diagnostic Treatment (RORBCDT). 
The entire project will be conducted using fictitious patients, physicians and 
clinical trial team who will be trained to participate in the simulation as real patients, 
physicians and clinical trial staff.  
 
Introduction 
Breast cancer (malignant breast neoplasm) is a cancer originating from breast 
tissue, most commonly from the inner lining of milk ducts or the lobules that supply the 
ducts with milk (Sariego, 2010). Cancers originating from ducts are known as ductal 
carcinomas; those originating from lobules are known as lobular carcinomas. Breast 
cancer is a disease of humans and other mammals; the overwhelming majority of cases in 
humans are women (US NIH).  
 
Real-Time Operating Room Breast Cancer Diagnostic Treatment 
The RORBCDT clinical trial is designed to assess the value of a new breast 
cancer operating room diagnosis technology “Intra-operative Diagnosis of Sentinel 
Lymph Node (Sentimag)” and real-time treatment option “Intra-operative Radiotherapy 
(IORT)”. Generally, when breast cancer surgery is performed, patients recover for a week 
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before chemo or radiotherapy protocols can begin.  However, under certain 
circumstances, radiotherapy can begin immediately in the operating room using a new 
technology.  First, Sentimag can detect for staging of certain types of cancer to see if they 
have spread to any lymph nodes. If the diagnose is positive, then the surgery will apply 
and then a new treatment device (IORT) can be used to treat the remaining cancerous 
tissues.  
 
Intra-operative Diagnosis of SLN- Sentimag 
A “sentinel” lymph node is defined to be the hypothetical first lymph node or 
group of nodes reached by metastasizing cancer cells from a primary tumor. The concept 
of the sentinel lymph node is important because of the advent of the Sentinel Lymph 
Node Biopsy (SLNB) technique, also known as a sentinel node procedure. This technique 
is used in the staging of certain types of cancer to see if they have spread to any lymph 
nodes, since lymph node metastasis is one of the most important prognostic signs. It can 
also guide the surgeon to the appropriate therapy. SLNB has been validated as an 
accurate predictor of the status of the lymph node basins. This technique introduces a 
new concept of selective lymphadenectomy based on the histological status of the 
sentinel lymph node. This enables the surgeon to stratify patients for appropriate surgery 
without submitting the majority of those without sentinel lymph node metastases to 
unnecessary regional lymph node dissection with its associated morbidity and cost.  This 
concept creates a major new opportunity for real-time stratification of patients for 
immediate surgery. However, until now, no real-time operating room diagnostic 
15 
 
 
 
technology exists to detect sentinel nodes in real time.  Recently, an intra-operative 
diagnosis of SLN- Sentimag was created (Keshtgar, n.d.) 
Usually, during surgery, a lymph gland called “the sentinel node” is taken from 
the armpit and tested for spread – if the test is positive, the patient will have to undergo a 
second operation. This new device, however, is an optical scanner which can be used in 
operating rooms during surgery. It allows for an instant assessment, and if needed, be an 
immediate further surgical procedure – which obviates the need for the patient to undergo 
a separate, second operation at a later date. Its technology relies on light and elastic 
scattering spectroscopy which displays a different optical signature for cancerous and 
non-cancerous cells, and leaves the sentinel node intact for any other tests which may be 
required (Keshtgar, n.d.) 
 
Intra-operative Treatment Radiotherapy- IORT 
Once a real-time diagnostic is available, then the treatment team needs a real-time 
therapy option to take advantage of the rapid diagnosis. The new Intra-operative 
Radiotherapy (IORT) provides an option to immediately treat the cancerous tissue while 
the patient is still in the surgery. 
Post-operative radiotherapy, which forms part of breast conserving therapy, may 
not need to encompass the whole breast. Apart from the consumption of huge resources 
and patients' time, post-operative radiotherapy deters many women from receiving the 
benefits of breast-conserving surgery, forcing them to choose a mastectomy instead. If 
radiotherapy could be given in the operating theatre immediately after surgery, many of 
these disadvantages could be overcome. IORT is an intensive radiation treatment that's 
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administered during surgery. IORT is used to treat cancers that are difficult to remove 
during surgery and there is a concern that microscopic amounts of cancer may remain. 
IORT allows direct radiation to the target area while sparing normal surrounding tissue. 
IORT will use radiotherapy during a surgical procedure, usually in the treatment of 
diffused neoplasia that cannot be completely removed by surgical methods alone. 
During IORT, women undergoing breast conserving surgery (lumpectomy) may 
receive their radiotherapy at the time of their breast cancer operation while still under 
anesthesia, completely replacing the need for a 6-7 week course of radiotherapy normally 
given after surgery ( Williams, 2011.) 
IORT takes just 20-35 minutes to administer and replaces 6-7 weeks of daily 
visits to the hospital for post-operative radiotherapy. IORT permits women to complete 
their cancer treatments sooner, allowing them a quicker return to their normal lives.  In 
this new approach the patient has just one dose of radiation, during the operation. It is 
done using a mobile radiotherapy machine. The probe is inserted into the breast so that it 
can target the exact site of the cancer. Then the surgeons leave the theatre while 
specialists deliver the radiation for about 30 minutes (Williams, 2011.) 
The objective of RORBCDT is to conduct a clinical trial to test the value of two 
new operating room breast cancer diagnostic and treatment devices.  The trial will 
include assessment surveys to collect data from breast cancer physicians and patients to 
assess their interest in participating in the clinical trials and completion surveys to assess 
impressions and possible problems during clinical trials.  
17 
 
 
 
The entire assessment and completion surveys and clinical trial will be conducted 
using fictitious patients, physicians and clinical trial team who will be trained to 
participate in the simulation as real patients, physicians and clinical trial staff. 
 
Real-Time Operating Room Breast Cancer Diagnostic Treatment RORBCDT 
Clinical Trial 
The RORBCDT is a two-arm clinical trial designed to test the efficacy of these 
real-time diagnosis and treatment devices.  In one arm of the trial, breast cancer surgery 
patients will be diagnosed but no real-time therapy will be given. In the other arm, breast 
cancer patients will be both diagnosed and treated by the intra-operative devices 
(Figure1). 
 
RORBCDT Site 
The breast care center, St. James hospital, UWM School of Public Health and 
Laboratory for Public Health Informatics and Genomics (LPHIG) will conduct a breast 
cancer clinical trial assessment surveys from patients and physicians in breast care center, 
St. James breast care center, which is located at 9210 W Ardmore Avenue, Milwaukee, 
WI 53226, and then based on the survey‟s results, conduct a longitudinal breast cancer 
clinical trial in this center. Breast care center provides education, research, and treatment 
for patients with diseases of the breast with a special emphasis on breast cancer, the most 
common form of cancer in women. Staffed by MCW physicians, the clinic provides 
convenient access to early detection screening, follow-up programs, and state-of-the-art 
techniques in cancer management. Patients receive specialized education about their 
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disease and its treatment, and emotional support for their change in body image and the 
threat of cancer. 
 
Public Health Informatics Tools Supporting RORBCDT 
Breast cancer clinical trial assessment surveys. 
Our objective to conduct these surveys is to assess the willingness of patients and 
physicians and the potential participants of breast cancer clinical trial using REDCap, to 
show the value and effectiveness of two new diagnostic and treatment technologies. 
Patients survey. 
We have created a survey containing 31 questions. Some questions have 
branching logic. It means that by choosing answers some more related questions to those 
answers will appear. This survey will ask patients about previous clinical trial 
experiences and their willingness to participate in clinical trials using the two new 
technologies. If they show their interest in participating in the clinical trial, they need to 
answer some more questions about their cancer and family history. Link to Assessment 
Survey-Patients: http://lphig.sph.uwm.edu/redcap/surveys/?s=cmuRdD 
Physicians Survey. 
We have created a survey containing 26 questions. This Survey has Branching 
logics and will ask physicians about previous clinical trial experiences and their 
willingness to attend in our clinical trial. Link to Assessment Survey-Physicians: 
http://lphig.sph.uwm.edu/redcap/surveys/?s=rFz45s 
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Longitudinal breast cancer clinical trial. 
We will have a longitudinal clinical trial database containing information about 
our participants in the clinical trials, their cancer procedures and selected treatment.  
What is a clinical trial. 
The clinical trial is “the most definitive tool for evaluation of the applicability of clinical 
research. It represents a key research activity with the potential to improve the quality of 
health care and control costs through careful comparison of alternative treatments.” 
(NIH) A clinical trial is a biomedical or health-related research study in human beings 
that follows a pre-defined protocol (Understanding Clinical Trials, n.d.) A clinical trial is 
a prospective study to compare the effect and value of interventions. In prospective study, 
participants must be followed forward in time. Each participant must be followed from a 
well defined point, which becomes time zero or baseline for the study. This contrasts 
them with a control arm study (Friedman, P2.) The two kinds of clinical trial studies are 
called interventional and observational. Interventional studies are those in which the 
research subjects are assigned by the investigator to a treatment or other intervention, and 
their outcomes are measured. Observational studies are those in which individuals are 
observed and their outcomes are measured by the investigators (Understanding Clinical 
Trials, n.d.)In addition, treatment trials test experimental treatments, new combinations of 
drugs, or new approaches to surgery or radiation therapy. In our clinical trial project we 
will conduct an interventional treatment study.  
Benefits and risks. 
Clinical trials that are well-designed and well-executed are the best approach for 
eligible participants to: 
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1. Play an active role in their own health care. 
2. Gain access to new research treatments before they are widely available.  
3. Obtain expert medical care at leading health care facilities during the trial. 
4. Help others by contributing to medical research (Understanding Clinical Trials, 
n.d.) 
However, there are possible risks in clinical trials. 
1. There may be unpleasant, serious or even life-threatening side effects to 
experimental treatment. 
2. The experimental treatment may not be effective for the participant. 
3. The protocol may require more of their time and attention than would a non-
protocol treatment, including trips to the study site, more treatments, hospital 
stays or complex dosage requirements (Understanding Clinical Trials, n.d.) 
Clinical trial phases.  
Clinical trials are conducted in phases with different purpose and objectives: 
1. In phase I trials, researchers test an experimental drug or treatment in a small 
group of people for the first time to evaluate its safety, determine a safe dosage 
range, and identify side effects. 
2. In phase II trials, the experimental study drug or treatment is given to a larger 
group of people to see if it is effective and to further evaluate its safety. 
3. In phase III trials, the experimental study drug or treatment is given to large 
groups of people to confirm its effectiveness, monitor side effects, compare it to 
commonly used treatments, and collect information that will allow the 
experimental drug or treatment to be used safely. 
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4. In phase IV trials, post marketing studies delineate additional information 
including the drug's risks, benefits, and optimal use (Understanding Clinical 
Trials, n.d.) 
RORBCDT is a phase III clinical trial. The objective of RORBCDT is to assess 
the effectiveness of two intra-opeartive diagnostic and treatment devices. Half of the 
participants will receive single-day intra-operative radiotherapy (IORT) given at the time 
of surgery. The other half will receive conventional post-operative radiotherapy given 
over a 6-7 week period beginning after surgery. The goal of the trial is determine if intra-
operative diagnosis of SLN-Sentimag and single-day intra-operative radiotherapy-IORT 
is as effective as lymphoscintigraphy and 6-7 weeks conventional post-operative 
radiotherapy for the treatment of early stage invasive breast cancer. 
A randomized controlled trial is a scientific study in which different treatments 
are compared in an organized and objective manner. “Randomized” means that a 
computer will assign one of the two treatments to each patient similar to tossing a coin. 
“Controlled” means that the study is being performed under well-defined conditions to 
ensure that other variables do not impact the results. The goal of a randomized controlled 
trial is to eliminate bias so that the results of the study will be truly believable (USC, 
Department of surgery, n.d.) 
A randomized controlled trial is the best way to determine the safety and 
effectiveness of different treatments. In fact, it is because of randomized controlled trials 
that most women today can safely receive breast conservation therapy (lumpectomy + 
radiotherapy) instead of mastectomy, without fear of reducing the chances of surviving 
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breast cancer. Prior to these trials, mastectomy was the only treatment offered to women 
with breast cancer (USC, Department of surgery, n.d.) 
Clinical trial steps. (Figure2) 
Determination of subject eligibility. 
Prior to joining the study, a patient must meet with the LPHIG Research Team 
Representative at St.James to determine if she qualifies for this trial. This evaluation will 
include a physical examination, review of her mammograms and ultrasounds, and review 
of her pathology results. Additional radiology studies (mammograms, ultrasounds, and/or 
breast MRI) may also be requested prior to determining her eligibility for the study 
(Targit, n.d), (USC, Department of surgery, n.d.) 
Subject inclusion criteria: 
 Invasive (also called infiltrating) breast cancer 
 Breast cancer treatable with lumpectomy 
 Capable of receiving breast radiotherapy (not pregnant, no history of previous 
radiotherapy to the same breast, no connective tissue disorder) 
 None breastfeeding 
Subject exclusion criteria: 
 Multiple areas of breast cancer 
 Cancer in both breasts 
 Extensive non-invasive cancer (DCIS or Ductal Carcinoma in Situ). 
 Lymph nodes contain cancer metastasis. 
Informed Consent. 
23 
 
 
 
Informed consent is the process of teaching the key facts about a clinical trial to a 
patient before they decide whether or not to participate. It is also a continuing process 
throughout the study to provide information for participants. If a patient qualifies for the 
trial, she will be given an informed consent statement that clearly describes important 
aspects of the trial, including the benefits and risks of the different treatments. To help 
someone decide whether or not to participate, the trial investigators will review the 
informed consent statement with patient, answer any questions that she has, and request 
that she sign the informed consent statement to confirm willingness to participate in the 
Trial. If the participant's native language is not English, translation assistance can be 
provided. Then the research team provides an informed consent document that includes 
details about the study, such as its purpose, duration, required procedures, and key 
contacts. Risks and potential benefits are explained in the informed consent document. 
The participant then decides whether or not to sign the document. By signing of the 
informed consent statement, the patient indicates that she is interested in participating in 
the Trial and that she is willing to receive whichever treatment assigned to her. Informed 
consent is not a contract, and the participant may withdraw from the trial at any time. 
(Understanding Clinical Trials, n.d.) 
Randomization. 
Randomization is the preferred way of assigning participants to control and 
intervention groups (Friedman, 2010, p.42.) Randomized control studies are comparative 
studies with an intervention group and a control group; the assignment of the participants 
to a group is determined by the formal procedure of randomization. Randomization, in 
the simplest case, is a process by which all participants are equally likely to be assigned 
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to either the intervention or control group. (Friedman, 2010, p.43.) Green and Byar in 
their scheme confirmed that the randomized clinical trial is the strongest clinical trial 
design (Green, 1984.)  
There are three advantages of the randomized design over other methods for selecting 
controls (Byar, 1976.) Randomization tends to produce study groups comparable with 
respect to the measured and unknown prognostic factors, removes investigator bias in the 
allocation of participants, and guarantees that statistical tests will have valid significance 
levels (Byar, 1976.) 
After the informed consent statement is signed, a computer will randomly assign 
two treatments to the patient. Half of the participants will receive intra-operative 
diagnosis of SLN-Sentimag and single-day intra-operative radiotherapy-IORT and the 
other half will receive no real time lymphoscintigraphy and conventional post-operative 
radiotherapy.  
In any clinical trial, bias is one of the main concerns. Bias can be caused by 
conscious factors, unconscious factors or both. The general solution to the bias is to keep 
the patients and investigator blinded to the identity of the assigned intervention. In double 
blind studies, neither the patients nor the investigators know which patients are in each 
group.  In studies where double-blind is impossible, single blind or open study is favored.  
In an unblinded study or open trial, both the patient and investigator know to which 
intervention the patient has been assigned. In single blind studies, patients do not know 
whether they are in the control or study group, but the investigator does. Some kinds of 
trials can be conducted only in open trial. Such studies include those involving most 
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surgical procedures, comparisons of devices and medical treatment, and changes in 
lifestyle or learning technique (Friedman, 2010, p.82.) 
Scheduling. 
After treatment has been determined, the patient, the surgeon, and the radiation 
oncologist will schedule the date of her operation. If she has been assigned to receive 
Sentimag and IORT, she will receive them at the time of her breast cancer surgery while 
she is still under anesthesia. The radiotherapy treatment will take approximately 30-35 
and will add approximately 45 minutes to the length of the operation. On the other hand, 
if she had been assigned to receive lymphoscintigraphy, she will receive it in the same 
day or a day before surgery. If she had been assigned to receive conventional post-
operative radiotherapy, she will receive conventional post-operative radiotherapy over a 
6-7 week period after she has recovered from breast surgery. 
 
Breast cancer clinical trial completion surveys. 
Clinical trial completion survey- physicians. 
We have created a survey containing 16 questions. This survey is designed to 
collect data about possible problems which may occur during project and to assess the 
pros and cons of those two intra-operative technologies. Ina addition, it will measure the 
physicians‟ overall satisfactions with the clinical trial. This survey will collect the 
physician‟s point of view regarding the clinical trial and their suggestions for improving 
future related studies. Link to completion survey- physicians: 
http://lphig.sph.uwm.edu/redcap/surveys/?s=X7CGwm 
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Clinical trial completion survey-patients. 
We have created a survey containing 8 questions. This survey is designed to 
collect data from patients participating in clinical trial in order to measure their overall 
satisfactions and to assess the quality of clinical trial design. This survey will also collect 
the patients suggestions for future trial improvement. Link to completion survey- 
Patients: http://lphig.sph.uwm.edu/redcap/surveys/?s=kFvVx9 
These surveys will be conducted using REDCap. In assessment surveys 
researchers will store and analyze data collected from women with breast cancer admitted 
in the breast care center, St. James hospital during 2010-2011. In addition, breast cancer 
physicians (Surgeons, Radiotherapists and Pathologists) will be asked to complete a 
survey designed for them. In completion surveys, researchers will collect information 
from patients and physicians who were participating in a clinical trial. REDCap will help 
us to design a longitudinal clinical trial database to do the designed project. Our research 
participants are LPHIG research team, St. James breast care center physicians and staff, 
patients and a project coordinator.  
 
Participants 
Breast cancer physicians.  
In this project we will ask St. James breast care center physicians (surgeons, 
radiotherapists and pathologists) to participate in our project by filling out the assessment 
and completion physician‟s surveys. We will provide a link to the Survey. So they can fill 
out the survey through any computer. We do not ask identifying question, so the collected 
information are anonymous. 
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Breast Cancer patients or study population. 
The study population is the subset of the population with the condition or 
characteristics of interest defined by the eligibility criteria. (Friedman, 2010, p30.) 
Patients are our population in a large and playing an important role in our project.  We 
have designed a separate survey for women with breast admitted in the breast care center, 
St. James hospital during 2010-2011 to access the potential participant in our clinical trial 
project.  For patient‟s convenience, the survey will be available both in print and online. 
There will be an option for patients who have a disability to fill out the form with the help 
of our researchers in the Cancer Center. We do not ask identifying questions, so the 
collected information is anonymous. 
As we discussed in “Determine Subject Eligibility” in “Clinical Trial Steps”, In 
order to participate in the Trial, some inclusion criteria must be met. 
To see the Relationship of study sample to study population and population at large see 
the “Fig1” in the appendices. 
LPHIG researchers.  
LPHIG researchers are responsible for collecting, storing, analyzing data using 
REDCap. They have designed surveys and made it available to patients and physicians. 
They will modify the Survey and retake it if necessary. In addition, some LPHIG 
researchers should be in the Cancer center in case a patient need help to fill out the 
survey. They are also responsible to train physicians how to work with REDcap. LPHIG 
researchers are responsible to analyze the data and propose it to the Cancer center to help 
them decide about starting clinical trial by using those new technologies in their center.  
If the center decides to have clinical trial, LPHIG researchers are responsible to create a 
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longitudinal project and help the cancer center to schedule events for patients and 
conduct the clinical trial project using  REDCap. After finishing the project, LPHIG 
members are responsible to conduct a Clinical Trial Completion Surveys to collect the 
feedback from conducted project. 
Breast care center staff. 
If the center decides to conduct a clinical trial, staff is responsible to do the 
project in the center by using Longitudinal Clinical Trial Database designed by LPHIG 
Researchers.  
They are responsible to collect data from patients and schedule appointments for them 
and follow up their treatments. 
Research coordinator. 
The research coordinator is responsible for coordinating all participants in the 
project to perform a high quality research study and get the proper results. To do so, the 
coordinator is responsible to train all LPHIG researchers how to work with REDCap. In 
addition he/she is responsible for any software problems or administrative issues. 
 
RORBCDT Implementation and Results 
The clinical trial simulation was executed using the REDCap environment 
(Appendix A.) The surveys were conducted and false data was collected for participating 
fictitious patients. 
We assumed that we have conducted assessment surveys a year before starting 
clinical trial. The objective of conducting assessment surveys was to assess the potential 
participants for the future clinical trial studies. As we aimed to show the REDCap value, 
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we assumed there are enough potential participants to start clinical trial, so we have 
generated false data to show the patients and physicians interest in participating in 
clinical trial. (Appendix D). The fictitious assessment survey results show that 80% of 
patients have heard about clinical trial (Table 5) and 40 % of patients participated in other 
clinical trials before (Table 6) 60% of participants indicate their interest to participate in 
breast cancer clinical trial (Table 8) and 87% of those who were interested specifically 
would like to attend RORBCDT clinical trial (Table 9). 
         
Table 8      Table 9 
The results also show that 47.4 % of physicians have experience participating in 
clinical trials as investigator (Table 32) and 26.3% of them have already attended in 
similar intra-operative diagnosis of SLN using Sentimag(Table 34) and 36.8 % have 
experience of IORT (Table 38) and 88.9 % would like to attend RORBCDT clinical trial 
(Table 36), (Table 39).  
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Table 36 
By conducting the assessment surveys we assessed that if we start the clinical trial 
there will be at least 5 physicians and 50 patients interested and eligible to participate. 
We also assumed that we have 8 fictitious physicians who are interested in participating 
in clinical trials. After designing the clinical trial, we asked the physicians to start 
recruiting fictitious patients and inform them about the RORBCDT clinical trial.  
After assessing potential participants, the clinical trial was executed in REDCap 
environment (Appendix A).  The eligibility determination was completed (Figure 20) and 
50 eligible patients signed the informed consent from (Appendix F). By randomization, 
we assigned 25 patients in each arm and scheduled them for following visits, surgery and 
radiotherapy depending on the arm they were assigned to (Figure 16), (Figure 17). 
After clinical trial completion, we have conducted completion patients and 
physicians surveys (Appendix E). The aim of conducting patients survey was to assess 
the quality of the clinical trial design and measure the overall satisfaction of patients 
participated in the trial and get their feedback for future improvements. Based on the 
results we have gained, 88.4% of patients indicated that they received required 
information in order to participate in clinical trial (Table 41) and 90% indicated that they 
have been informed about possible side effects (Table 42). And most of the patients were 
satisfied about participating in breast cancer clinical trial (table 46) and 90.7 % 
recommend other patients to attend such clinical trials (Table 47). 
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Table 46     Table 47 
The physicians‟ survey shows that 50% of physicians have a positive opinion 
about the executed clinical trial and 37.5 % indicated that the clinical trial could be better 
(Table 48). 100% of physicians prefer using intra-operative diagnostic devices rather than 
standard technology (Table 50). All physicians were satisfied with this clinical trial 
(Table 51) and thought these technologies will have an impact on breast cancer treatment 
(Table 53). 
   
Table 51     Table 54 
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Chapter4 
Discussion, Conclusion and Limitation 
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Discussion 
To prepare for this trial we conducted Physicians and Patients Assessment 
Surveys. We gathered false data from fictitious physicians and patients. Based on the 
generated result (Tables 5, 6, 8, 9, 32, 34, 36, 38, 39) we recruited the clinical trial 
participants and executed Real Time Operating Room Breast Cancer Diagnostic 
Treatment (RORBCDT) clinical trial in the REDCap environment. The objective of 
executing RORBCDT was to assess the value of REDCap. 
REDCap has provided a free environment to conduct Clinical and Translational 
studies. We took benefit of using REDCap in designing and executing RORBCDT. 
REDCap has features which are very useful in these studies. The web based access to 
data across academic departments and institutions helps researchers to conduct 
collaborative study, which we have done in RORBCDT. The REDCap installed on 
LPHIG local machines and researchers no matter where they are can access to the 
REDCap through this link: www.lphig.sph.uwm.edu/redcap (Figure 3). The user 
authentication and role-based security helps researchers to conduct studies in a secure 
environment and grant access to the participants based on their roles in the study. In our 
study we took benefit of this role-based feature and granted access to the LPHIG 
researchers based on their roles in conducting project (Figure 9),(Figure10). REDCap 
survey is a very useful feature of REDCap. This will allow researchers to collect data 
from participants by simply sending a survey link or manually entering survey result in a 
system or giving a PDF version of the survey to participants. In our Project we have 
conducted four surveys before and after executing RORBCDT in REDCap (Appendix D), 
(AppendixE). We sent the survey links to our participants and analyzed the data using 
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Graphical data view and stats which is another good feature of REDCap (AppendixG). 
Intuitive electronic case report forms help researchers to get the customizable report 
based on their needs (Figure 19).  File repository helps researchers to keep track of all 
documents stored in different projects and events. In our clinical trial project we could 
keep track of patients‟ informed consent forms which were uploaded for each patient in 
informed consent event (Figure 18). Data export functions for common statistical 
packages let researchers easily export data to some statistical package format for further 
analyzing (Figure 11) Data import function is very useful in clinical studies which 
facilitates bulk import of data from other systems (Figure 12). REDCap will let research 
coordinators to create different kind of projects such as longitudinal projects and Surveys 
(Figure 7).The longitudinal project provides scheduling module which lets investigators 
to schedule patients‟ visits and track them in a calendar (Figure 16), (Figure17). In the 
longitudinal project it is possible to assign patients in different arms (Figure 21), 
(Figure22) and compare them using data comparison tools (Figure 13). Therefore, 
REDCap provides a good environment to conduct longitudinal projects such as clinical 
trial as we have done it. 
Conclusion 
The Electronic Health Record (EHR) Systems emerged to facilitate some of the 
essential aims of medical informatics which are diagnostic, therapy, therapy simulation, 
health care information systems and medical documentation (Haux, 1997). Clinical 
informaticians are playing an important role in transition from paper records to electronic 
ones. Recently, the number of electronic solutions and applications to manage electronic 
health record is increasing. Therefore, clinical informaticians who bring expertise at the 
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intersection of health care and IT to assure successful adoption and use of HIT and the 
information within it are responsible to assess the values of different applications prior to 
adopting them in their health facilities. By conducting RORBCDT, a simulated breast 
cancer clinical trial, we, as informaticians aimed to show the value of REDCap as a tool 
supporting health informatics. REDCap installed on both Windows (Appendix B) and 
Unix systems (Appendix C) and is easy to learn. The executed assessment and 
completion surveys and clinical trial in REDCap environment show that REDCap 
provides cleaner data which is particularly good at enforcing certain aspects of data 
quality. REDCap also provides more efficient processes which help guide the site 
through the series of study events, requesting only the data needed for the particular 
patient‟s circumstance at a particular time. It faculties the process of clarifying data 
discrepancies with tools for identifying and resolving data issues with sites, and can help 
reduce the number of in-person site visits required during a trial. In addition REDCap 
provides faster access to data; web-based system can provide near real-time access to 
data in a clinical trial. This insight enables faster decision making, and can support 
adaptive trial designs. Therefore, REDCap is a valuable tool which provides a free and 
secure environment to support health care informatics and conduct translational and 
clinical studies. 
 
Limitations 
Beside the value of REDCap, it has some limitations. Multiple surveys in a single 
project were always needed when we were designing this project. REDCap has an option 
to create single survey projects which is not enough sometimes. In addition, to conduct 
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clinical trials, there is a need of financial management which is available in other Clinical 
Trial Management Systems. Therefore, it is not the best environment to conduct the 
clinical trial. However, by considering its cost in comparing to other solutions it is still a 
good choice to conduct simple clinical trials in health facilities such as universities.   
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REDCap 
“REDCap” (Harris, P. A., et al, 2009) is a free, secure, web-based application 
designed to support data capture for translational and clinical research studies. The 
system was developed by a multi-institutional consortium initiated at Vanderbilt 
University. Data collection is customized for each study or clinical trial by the research 
team. REDCap is usefull for Collecting and tracking information and data from research 
studies, scheduling study events (e.g., patient visits), conducting surveys 
REDCap Features 
REDCap provides user-friendly web-based case report forms, real-time data entry 
validation (e.g. for data types and range checks) and the ability to set up a calendar to 
schedule and track critical study events (Figure 16), (Figure17). Also, designated users 
can assign different levels of access for each member of the research team (Figure 9), 
(Figure10).  REDCap Survey provides a powerful tool for creating and managing surveys 
in the web browser. Collect responses from survey participants by: 
 Sending a link to survey participants via email 
 Entering data manually, and/or  
 Posting a link on survey participants‟ website  
REDCap Survey gives survey participants the option to keep their participant responses 
anonymous, or track and identify responses by building an email contact list.  
REDCap offers the following features which are very useful to collect data for 
research studies and conduct different kind of projects (e.g. longitudinal projects). 
REDCap is  
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 Fast and has Quick project start-up. Clinical report forms can be implemented 
without the need for a programmer (Figure 19). 
 Easy. It has intuitive user interface and work flow, online training materials which 
is readily available.  (Figure 4), (Figure 6). 
 Fully customizable. You are in control of shaping your database. (Figure 8) 
 Secure. It has backed up offsite nightly and hosted in a secure environment. 
 Web-based. You are able to enter data or build your database from anywhere in 
the world over a secure web connection with authentication and data logging. 
(Figure 3), (Figure 9), (Figure14). 
 A data export tool. You can export data to common data analysis packages, data 
export function for Excel, SAS, Stata, R, and SPSS. (Figure 11) 
 A data import tool.  It has data import capability through Microsoft Excel.(Figure 
12) 
 A multi-site utility. It can be used by researchers from multiple sites and 
institutions. 
 An autonomous user management tool. Research groups have complete autonomy 
and control to add new users and set several levels of specific user rights.(Figure 
9). 
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Appendix B 
Installing REDCap v4.5.1 on a Local 
Windows Machine
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Apache HTTPD Installation 
Download the Apache Win32 Binary including OpenSSL 0.9.8o (MSI Installer): httpd-
2.2.17-win32-x86-openssl-0.9.8o.msi 
Run the installation package.  Choose a typical installation. 
The default installation directory is C:\Program Files (x86)\Apache Software 
Foundation\Apache2.2 
After installation open a web browser and enter http://localhost/ 
PHP Installation 
Download the VC6 x86 Thread Safe PHP binaries (MSI installer):  php-5.3.4-Win32-
VC6-x86.msi 
Run the installation package.  Choose Apache 2.2.x Module.  Choose a typical 
installation. 
When asked for Apache‟s location enter C:\Program Files (x86)\Apache Software 
Foundation\Apache2.2\conf 
The default installation directory is C:\Program Files (x86)\PHP 
Run windows cmd prompt. 
Copy "C:\Program Files (x86)\PHP\php5ts.dll" "C:\Program Files (x86)\Apache 
Software Foundation\Apache2.2\bin" 
cd "\Program Files (x86)\Apache Software Foundation\Apache2.2\conf" 
notepad httpd.conf 
Find “PHPIniDir” 
Change to: 
PHPIniDir "C:\Program Files (x86)\PHP\" 
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Find “LoadModule php5_module” 
Change to:  LoadModule php5_module "C:\Program Files 
(x86)\PHP\php5apache2_2.dll" 
Save and exit notepad. 
cd "\Program Files (x86)\PHP\" 
notepad php.ini 
Find “doc_root” 
Change to: 
doc_root = 
Save and exit notepad. 
cd "\Program Files (x86)\Apache Software Foundation\Apache2.2\htdocs" 
notepad phpinfo.php 
Insert: 
<?php 
phpinfo(); 
?> 
Save and exit notepad. 
Completely stop and then start Apache services by using the tool icon to open the Apache 
control panel. 
After configuration open a web browser and enter http://localhost/phpinfo.php 
MySQL Installation 
Open the Windows security center firewall control panel, and add an exception for port 
3306 using TCP. 
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(An advanced setting, choose new rule, and port) 
Download the MySQL Community Server Windows (x86, 32-bit), (MSI Installer):  
mysql-5.5.8-win32.msi 
Run the installation package.  Choose a complete installation. 
When asked to run configuration, choose a) detailed, b) developer machine, 
c)multifunctional database, d) decision support, e) TCP/IP & strict mode, f) standard 
character set, g) windows service & include Bin directory 
Enter a root password:  fengshui 
The default installation directory is C:\Program Files (x86)\MySQL\MySQL Server 5.5 
Run windows cmd prompt. 
Copy "C:\Program Files (x86)\MySQL\MySQL Server 5.5\lib\libmysql.dll" "C:\Program 
Files (x86)\Apache Software Foundation\Apache2.2\bin" 
After configuration, in the command prompt type:  mysqlshow -uroot –pfengshui 
PEAR Installation 
Download the PEAR package (TGZ File):  PEAR-1.9.1.tgz 
Unzip file contents (PEAR-1.9.1.tgz) into C:\temp 
Run windows cmd prompt. 
Move "C:\temp\PEAR-1.9.1\PEAR.php" "C:\temp\PEAR-1.9.1\PEAR\" 
Move "C:\temp\PEAR-1.9.1\PEAR5.php" "C:\temp\PEAR-1.9.1\PEAR\" 
Run windows file explorer. 
Move the folder “PEAR” to the directory “C:\Program Files (x86)\PHP\” 
notepad php.ini 
Find “include_path =” for Windows 
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Delete the semicolon before “include_path =” 
Change “include_path =” to: 
include_path = ".;C:\Program Files (x86)\PHP\PEAR" 
Save and exit notepad. 
Completely stop and then start Apache services by using the tool icon to open the Apache 
control panel. 
PEAR Auth Installation 
Download the PEAR Auth package (TGZ File):  Auth-1.6.4.tgz 
Unzip file contents (Auth-1.6.4.tgz) into C:\temp 
Run windows file explorer. 
Move the folder “Auth” to the directory “C:\Program Files (x86)\PHP\PEAR\” 
Move the file “Auth.php” to the directory “C:\Program Files (x86)\PHP\PEAR\” 
Completely stop and then start Apache services by using the tool icon to open the Apache 
control panel. 
PEAR DB Installation 
Download the PEAR DB package (TGZ File):  DB-1.7.14RC2.tgz 
Unzip file contents (DB-1.7.14RC2.tgz) into C:\temp 
Run windows file explorer. 
Move the folder “DB” to the directory “C:\Program Files (x86)\PHP\PEAR\” 
Move the folder “doc” to the directory “C:\Program Files (x86)\PHP\PEAR\” 
Move the folder “tests” to the directory “C:\Program Files (x86)\PHP\PEAR\” 
Move the file “DB.php” to the directory “C:\Program Files (x86)\PHP\PEAR\” 
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Completely stop and then start Apache services by using the tool icon to open the Apache 
control panel. 
phpMyAdmin Installation 
Download the phpMyAdmin all languages (ZIP file):  phpMyAdmin-3.3.8.1-all-
languages.zip 
Unzip file contents (phpMyAdmin-3.3.8.1-all-languages.zip) into C:\Program Files 
(x86)\Apache Software Foundation\Apache2.2\htdocs 
Rename the folder from “phpMyAdmin-3.3.8.1-all-languages” to “phpMyAdmin” 
Run windows cmd prompt. 
Mkdir "C:\Program Files (x86)\Apache Software 
Foundation\Apache2.2\htdocs\phpMyAdmin\config" 
After creating the config folder open a web browser and enter 
http://localhost/phpMyAdmin/setup/index.php 
The phpMyAdmin setup script will run. 
In the configuration file section, select “save”. 
Run windows cmd prompt. 
Cd "\Program Files (x86)\Apache Software 
Foundation\Apache2.2\htdocs\phpMyAdmin\config" 
Move config.inc.php .. 
Open a web browser and enter http://localhost/phpMyAdmin 
REDCap Source Code Installation 
Unzip file contents (redcap4.5.1.zip)into C:\temp 
Run windows file explorer. 
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Move the folder “redcap” to the directory “C:\Program Files (x86)\Apache Software 
Foundation\Apache2.2\htdocs” 
Open a web browser and enter http://localhost/redcap/install.php 
Open a second window in your web browser and enter 
http://localhost/phpMyAdmin/index.php 
Run windows cmd prompt. 
Cd "\Program Files (x86)\Apache Software Foundation\Apache2.2\htdocs\phpMyAdmin" 
notepad config.inc.php 
Add the following lines following other $cfg lines: 
$i=0; 
$i++; 
$cfg['Servers'][$i]['user']          = '###'; 
$cfg['Servers'][$i]['password']      = '###'; 
$cfg['Servers'][$i]['auth_type']     = '###' 
Save and exit notepad. 
Login to phpMyAdmin with the user/password. 
In the field under the heading 'Create new database' type in the name “redcap”, and click 
“create”. 
On the main page of phpMyAdmin click the 'Privileges' link, and then near the middle of 
the page click the 'Add a new User' link. 
Enter the username: “LPM”, host: “localhost”, and password “fengshui”, and click “Go”. 
Run windows cmd prompt. 
Cd "\Program Files (x86)\Apache Software Foundation\Apache2.2\htdocs\redcap" 
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notepad database.php 
Change to: 
$hostname  = '###'; 
$db   = '###'; 
$username  = '###'; 
$password  = '###'; 
$salt = '###'; 
Save and exit notepad. 
Reload webpage http://localhost/redcap/install.php 
Accept all default options in Step 3 and click on “Save Changes”. 
In the phpMyAdmin webpage, click the redcap link on the left panel to choose the redcap 
database, click on the „SQL‟ link, and then copy and paste the SQL code from Step 4 into 
the text box in phpMyAdmin, and click “Go”. 
Open web browser and enter http://localhost/redcap/redcap_v4.5.1/test.php (or click on 
the link in Step 5) 
Initial and 1-5 tests should be successful.  It is ok if some additional tests fail. 
Open web browser and enter http://localhost/redcap/index.php 
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Appendix C  
Install REDCap v4.5.1 on local 
Synology DSM 3.2 
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This page describes how to install and test the following 3rd party Unix software 
packages required by REDCap:  
PHP 
If PHP is not installed, it is available through the PHP Group 
( http://www.php.net/downloads.php).  
In Synology DSM 3.2, PHP is located in Control panel/Network services/ web services/ 
PHP settings.  
/etc.defaults:/usr/bin/php:/usr/syno/synoman:/etc:/var/run:/tmp:/var/spool/php:/volume1/
@tmp/php:/var/services/web:/var/services/photo:/var/services/blog:/var/services/homes:/
volume1/web/redcap/Include/pear 
MySQL 
If MySQL is not installed, it is available through MySQL AB 
( http://www.mysql.com/downloads).   
phpMyAdmin 
If phpMyAdmin is not installed, it is available through the phpMyAdmin Project 
( http://www.phpmyadmin.net/home_page/index.php). Or 
http://www.synology.com/support/download.php?lang=enu&b=4%20bays&m=DS411j 
PEAR Installation 
Download the PEAR package (TGZ File):  PEAR-1.9.1.tgz 
Unzip file contents (PEAR-1.9.1.tgz) into Lphig/web/redcap/Include 
Find “include_path =” for Linux 
Delete the semicolon before “include_path =” 
Open php.ini in notepad Change “include_path =” to: 
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include_path = ".:/volume1/web/redcap/Include/pear" 
Save and exit notepad. 
Create a notepad file in home/web/redcap/pear and name it “.pearrc”and put this content 
in to the file: 
#PEAR_Config 0.9 
php_value include_path ".:/home/your_cpanel_username/your_include_path" 
 
save file and close it. 
Completely stop and then restart Synology. 
PEAR Auth Installation 
Download the PEAR Auth package (TGZ File):  Auth-1.6.4.tgz 
Unzip file contents (Auth-1.6.4.tgz) into C:\temp  
And move the file to home/web/redcap/include/pear 
Completely stop and then start Synology. 
PEAR DB Installation 
Download the PEAR DB package (TGZ File):  DB-1.7.14RC2.tgz 
Unzip file contents (DB-1.7.14RC2.tgz) into C:\temp 
And move the file to home/web/redcap/include/pear 
Move the folder “DB” to the directory “home/web/redcap/include/pear” 
Move the folder “doc” to the directory “home/web/redcap/include/pear” 
Move the folder “tests” to the directory “home/web/redcap/include/pear” 
Move the file “DB.php” to the directory “home/web/redcap/include/pear” 
Completely stop and then start Synology. 
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REDCap Source Code Installation 
Unzip file contents (redcap4.5.3.zip)into C:\temp 
Move the folder “redcap” to the directory “ home/web/redcap” 
Open a web browser and enter http://lphig.sph.uwm.edu/redcap/install.php 
Open a second window in your web browser and enter  http://lphig.sph.uwm.edu 
/index.php 
Run windows cmd prompt. 
Open phpMyAdmin in sinology menu  
notepad config.inc.php 
Add the following lines following other $cfg lines: 
$i=0; 
$i++; 
$cfg['Servers'][$i]['user']          = '###'; 
$cfg['Servers'][$i]['password']      = '###'; 
$cfg['Servers'][$i]['auth_type']     = '###' 
Save and exit notepad. 
Login to phpMyAdmin with the user/password. 
In the field under the heading 'Create new database' type in the name “redcap”, and click 
“create”. 
On the main page of phpMyAdmin click the 'Privileges' link, and then near the middle of 
the page click the 'Add a new User' link. 
Enter the username: “###”, host: “####”, and password “####”, and click “Go”. 
Cd "home\web\redcap" 
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notepad database.php 
Change to: 
$hostname  = '###'; 
$db   = '###'; 
$username  = '###'; 
$password  = '###'; 
$salt = '###'; 
Save and exit notepad. 
Reload webpage http://lphig.sph.uwm.edu/redcap/install.php 
Accept all default options in Step 3 and click on “Save Changes”. 
In the phpMyAdmin webpage, click the redcap link on the left panel to choose the redcap 
database, click on the „SQL‟ link, and then copy and paste the SQL code from Step 4 into 
the text box in phpMyAdmin, and click “Go”. 
Open web browser and enter http://lphig.sph.uwm.edu/redcap/redcap_v4.5.1/test.php (or 
click on the link in Step 5) 
Initial and 1-5 tests should be successful.  It is ok if some additional tests fail. 
Open web browser and enter http://lphig.sph.uwm.edu/redcap/index.php 
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Breast Cancer Clinical Trial 
Assessment Surveys 
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Appendix E  
Breast Cancer Clinical Trial 
Completion Surveys  
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Appendix F  
Informed Consent Form 
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 Data Analysis
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Breast Cancer Clinical Trial Assessment Surveys-Physicians 
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Figure 7: REDCap Project Home 
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Figure 9: Basic User Rights 
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Figure 12: Data Import Tool 
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Figure 15: Designate Instruments for the Events 
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Figure 16: Scheduling 
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Figure 21: Define Events
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Figure 22: Create Multiple Arms 
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